Avid Bioservices Inc (CDMO)

[bfiest]

From an expert that is knowledgeable on these trials.

“this is a Phase 2 study. it is not randomized and cannot be a registrational trial -
there needs to be substantial positive data for the FDA to approve the initiation of a Phase 3 registration trial. So the phase 1/2 in HCC and this trial in gastric which each combine with pembro are designed to develop the data required to convince the FDA to allow a phase 3 registration trial.”

Makes sense that milestones are not paid until they get into a registrational trial assuming the data warrants the next move into such a trial.
?